ESR1 and cancer: The cytotoxic activity of these compounds was evaluated against estrogen receptor-positive (ER+) and negative (ER−) human cancer cell lines, and compounds 254–256 showed inhibitory effects against A2780, 2008, A431, MCF-7, and HCT-15 cell lines with IC50 values ranging from 0.04–2.00 μM.